Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
92
Views
19
CrossRef citations to date
0
Altmetric
Original Research

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

Yuan Liu1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
,
Jing-Jing Zhao1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
,
Zi-Qi Zhou1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
,
Qiu-Zhong Pan1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
,
Qian Zhu1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
,
Yan Tang1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
,
Jian-Chuan Xia1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
De-Sheng Weng1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China;2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Republic of China
 show all
Pages 6691-6702 | Published online: 18 Jul 2019

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nadine Landolina, Francesca Romana Mariotti, Andrea Pelosi, Valentina D’Oria, Tiziano Ingegnere, Claudia Alicata, Paola Vacca, Lorenzo Moretta & Enrico Maggi. (2024) The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response. OncoImmunology 13:1.
Read now

Articles from other publishers (18)

Yu Mei, Ying Zhu, Kylie Su Mei Yong, Zuhairah Binte Hanafi, Huanle Gong, Yonghao Liu, Huey Yee Teo, Muslima Hussain, Yuan Song, Qingfeng Chen & Haiyan Liu. (2024) IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment. Cell Reports 43:3, pages 113835.
Crossref
Juan Cao, Jun-Hong Liu, Steven G. Wise, Jingchun Fan, Shisan Bao & Gui-Sen Zheng. (2024) The role of IL-36 and 37 in hepatocellular carcinoma. Frontiers in Immunology 15.
Crossref
Min Gu, Yuexinzi Jin, Xun Gao, Wenying Xia, Ting Xu & Shiyang Pan. (2023) Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process. Frontiers in Immunology 14.
Crossref
Baoyi Jiang, Yulin Zhou, Yanting Liu, Siqi He, Baojian Liao, Tieli Peng, Leyi Yao & Ling Qi. (2023) Research Progress on the Role and Mechanism of IL-37 in Liver Diseases. Seminars in Liver Disease 43:03, pages 336-350.
Crossref
Maria Papasavva, Styliana Amvrosiou, Katerina-Marina Pilala, Konstantinos Soureas, Panayiota Christodoulou, Yuan Ji, Konstantinos Stravodimos, Damo Xu, Andreas Scorilas, Margaritis Avgeris & Maria-Ioanna Christodoulou. (2023) Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform. International Journal of Molecular Sciences 24:11, pages 9258.
Crossref
Jiahuan Tan, Tenghan Xu, Yanling Gou, Honglin Wang, Zongwen Liang, Yingying Cao, Han Wang, Yangyang Yu, Na Jiao & Zongfeng Zhang. (2022) CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis. Stem Cell Research & Therapy 13:1.
Crossref
Panayiota Christodoulou, Theodora-Christina Kyriakou, Panagiotis Boutsikos, Maria Andreou, Yuan Ji, Damo Xu, Panagiotis Papageorgis & Maria-Ioanna Christodoulou. (2022) Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. Biomedicines 10:12, pages 3037.
Crossref
Yuntao Ma, He Su, Xuyun Wang, Xiangdong Niu, Yang Che, Brett D. Hambly, Shisan Bao & Xiaopeng Wang. (2022) The role of IL-35 and IL-37 in breast cancer – potential therapeutic targets for precision medicine. Frontiers in Oncology 12.
Crossref
MingHua Cui, YueHui Liu, Li Cheng, Tao Li, YongZhi Deng & Da Liu. (2022) Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment. Frontiers in Immunology 13.
Crossref
Ling Ni. (2022) Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer. Frontiers in Immunology 13.
Crossref
Jie Dang, Zhiyun He, Xiang Cui, Jingchun Fan, David J. Hambly, Brett D. Hambly, Xun Li & Shisan Bao. (2022) The Role of IL-37 and IL-38 in Colorectal Cancer. Frontiers in Medicine 9.
Crossref
Yanglin Zhu, Hong Qin, Kui Ye, Chenglu Sun, Yafei Qin, Guangming Li, Hongda Wang & Hao Wang. (2022) Dual role of IL-37 in the progression of tumors. Cytokine 150, pages 155760.
Crossref
Lijie Li, Zhouzhou Liao, Mingzhu Ye & Jianfa Jiang. (2021) Recombinant human IL-37 inhibited endometriosis development in a mouse model through increasing Th1/Th2 ratio by inducing the maturation of dendritic cells. Reproductive Biology and Endocrinology 19:1.
Crossref
Najmeh Farahani, Fathollah Mohagheghi, Ghasem Mosayebi, Ali Ghazavi & Ali Ganji. (2021) Reduced IL-37 gene expression and CD8 T lymphocytes in patients with metastatic breast cancer. Breast Disease 40:4, pages 235-240.
Crossref
Mei Wang. (2021) The Role of IL-37 and IL-38 in Obstetrics Abnormalities. Frontiers in Medicine 8.
Crossref
Zhangci Su & Xiaoan Tao. (2021) Current Understanding of IL-37 in Human Health and Disease. Frontiers in Immunology 12.
Crossref
Xiaofeng Mu, Qi Zhao, Wen Chen, Yuxiang Zhao, Qing Yan, Rui Peng, Jie Zhu, Chunrui Yang, Ketao Lan, Xiaosong Gu & Ye Wang. (2021) IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation. Frontiers in Oncology 10.
Crossref
Yoojung Kwon, Misun Kim, Youngmi Kim, Hyun Suk Jung & Dooil Jeoung. (2020) Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages. Frontiers in Immunology 11.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.